Pfizer CEO says COVID-19 vaccine data for kids under age 5 may come in late October
Updated: 2021-09-15 09:42:43 KST
Pfizer is planning to revealing results of COVID-19 vaccine clinical trials for children aged six months to five years as early as the end of October.
The CEO of the company, Albert Bourla, made the remarks Tuesday during an interview at Research America's 2021 National Health Research Forum.
He added data for five to eleven year olds will come much sooner, and the FDA could approve their use as early before the end of September.